Enhanced Conversational Recast for Childhood Language Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help children with developmental language disorders improve their language skills. The study will explore two approaches: one that explains the meaning of verbs and another that does not. Participating children will attend a half-day summer camp for six weeks, receiving specialized language treatment called Enhanced Conversational Recast Therapy (ECR). Ideal candidates are children aged 4 to 6 who struggle with developing language skills but do not have hearing loss or other disabilities. As an unphased trial, this study offers a unique opportunity for children to receive specialized language support in a fun and engaging environment.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that Enhanced Conversational Recast is safe for children with language disorders?
Research shows that Enhanced Conversational Recast therapy improves language skills in children with language disorders. Studies have not found any safety concerns, indicating that children handle it well. This therapy helps kids learn grammar faster and more effectively than other methods. The research has reported no negative effects. Therefore, parents considering this trial can feel confident about the safety of this treatment for their children.12345
Why are researchers excited about this trial?
Enhanced Conversational Recast is unique because it takes a fresh approach to treating childhood language disorders. Unlike traditional methods that focus solely on grammar, this technique incorporates semantic support by explaining the meanings of verbs, giving children a better understanding of language use. Researchers are excited about this method because it could enhance grammatical learning by making language more meaningful for children. This additional layer of semantic understanding might lead to more robust language development compared to standard grammar-focused treatments.
What evidence suggests that this trial's treatments could be effective for childhood language disorders?
Research has shown that Enhanced Conversational Recast is a promising method for helping children with developmental language disorder (DLD). In this trial, one group of children will receive grammatical treatment with semantic support, while another group will receive grammatical treatment without semantic support. Studies have found that various approaches to conversational recasting can significantly improve language skills, particularly grammar, in children with language difficulties. Specifically, one study discovered that this method helped children understand grammar rules better than other techniques. By altering how these recasts are delivered, the treatment can effectively enhance learning. The evidence suggests that Enhanced Conversational Recast could be a valuable tool for developing language skills in young children with DLD.12367
Are You a Good Fit for This Trial?
This trial is for children aged 4-6 who struggle with language development and have been diagnosed with a developmental language disorder. They should not have other conditions that could affect learning. Participants will be tested to confirm their diagnosis before joining.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessment of morpheme use for potential treatment targets over three days
Treatment
Children receive treatment designed to improve language skills through child-friendly activities for six weeks
Follow-up
Participants are monitored for retention of learning approximately six weeks after the end of treatment
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Conversational Recast
Enhanced Conversational Recast is already approved in United States for the following indications:
- Developmental Language Disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor